Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?
Read More Pharma Industry News Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma Epizyme has been granted priority review by the US Food and Drug Administration (FDA) for the use of… bypharmanewsdailyFebruary 17, 2020
